Publication | Closed Access

Discovery of a potent and highly selective PDK1 inhibitor via fragment-based drug discovery

Molecular DockingFragment-based Drug DiscoveryDrug TargetBiochemistrySelective Pdk1 InhibitorMedicineRational Drug DesignPharmacologyDrug Discovery